Career Center

Event

Title:

Sarbanes Oxley Today: Corporate Governance in Life Sciences Compnies
Date: January 20, 2009
Time: 8:30am

Location:

NOVA, Room 510
505 W Olive Ave
Sunnyvale, CA 94086-7621
directions to NOVA

Sponsor: Bio2Device Group

Event details:

The Sarbanes-Oxley Act was a step toward providing greater protection for the public capital markets.  The Act itself has changed and adapted over the last five years, and its effects can be seen already in the government and insurance and will undoubtedly influence new regulatory oversight arising from the current market challenges.  BPM will focus discussion on the Act’s goals relating to corporate governance and risk management and how attention to those issues can improve the operations of Life Science Companies.

Scott Taylor, CPA, a partner in the Assurance Services practice and a co-leader of the Life Science group at Burr, Pilger & Mayer LLP has 24 years of public accounting and private industry experience.  His experience includes investment, real estate, health care, technology, software, biotech, nonprofit, and financial service industries.  He consults with public and private company management on a variety of accounting and tax services including financial statements, audits, implementation of accounting systems, internal control evaluations preparation of forecasts and budgets, litigation support, and business plan development.

Mr. Taylor is a Certified Valuation Analyst with an MS in Taxation – Golden Gate University and BA in Business Economics – University of California, Santa Barbara.

Clark Keeler, Director of Burr, Pilger & Mayer LLP’s Internal Control and Risk Management Practice, is a financial executive with broad experience in leading both finance and operations teams. He has proven his leadership capabilities in directing complex projects in diverse industries and organizational environments.  His expertise is focused on managing growth and mitigating organizational risk, while improving existing infrastructure, systems and internal controls.  He is a skilled strategist with a long track record of successfully helping clients create new business opportunities while identifying and implementing cost controls and process improvements. 

Mr. Keeler has thirty years of experience related to change management experience in both business finance and operations covering start-ups, turnarounds, merger & acquisitions, divestitures, as well as systems and business development, redesign and integration.  He has extensive experience in leasing, distribution, manufacturing, transportation, retail, technology, life science and restaurant industries.

Mr. Keeler also has five years experience operating a private consulting practice focused on financial management, internal control compliance and improved risk management.  He has also served as the Chief Financial Officer for three companies.  Mr. Keeler’s practice emphasizes the integration of strong internal controls with process improvements, and the optimization of internal financial systems.

Additional information and/or registration:

Bio2Device Group

Stanford Medicine Resources:

Footer Links: